Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial

Author： Fontein Duveken   Houtsma Daniel   Nortier Johan   Baak-Pablo Renee   Kranenbarg Elma   Straaten Tahar   Putter Hein   Seynaeve Caroline   Gelderblom Hans   Velde Cornelis   Guchelaar Henk-Jan  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.144, Iss.3, 2014-04, pp. : 599-606

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients

By Ferraldeschi Roberta  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1191-1198

Springer Publishing Company

Access to resources Recommend Favorite

SNP rs2470152 in CYP19 is correlated to aromatase activity in Chinese polycystic ovary syndrome patients

By                        

Molecular Medicine Reports, Vol. 5, Iss. 1, 2012-01 ,pp. : 245-249

Spandidos Publications

Access to resources Recommend Favorite

Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events

By Anwar Sidra   Tan Wei   Hong Chi-Chen   Admane Sonal   Dozier Askia   Siedlecki Francine   Whitworth Amy   DiRaddo Ann Marie   DePaolo Dawn   Jacob Sandra M.   Ma Wen Wee   Miller Austin   Adjei Alex A.   Dy Grace K.  

Cancers, Vol. 9, Iss. 7, 2017-06 ,pp. : 73-73

MDPI

Access to resources Recommend Favorite

Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 12, Iss. 2, 2017-06 ,pp. : 136-147

Bentham Science Publishers

Access to resources Recommend Favorite

Genomic risk prediction of aromatase inhibitor‐related arthralgia in patients with breast cancer using a novel machine‐learning algorithm

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 240-253

John Wiley & Sons Inc

Access to resources Recommend Favorite